eClinicalWorks and healow Genie to Assist Large Georgia Pain Management Institute Manage Substantial Influx of Patient Calls
'I believe that healow Genie can help us data mine our calls,' said Cheraire Lyons, Vice President of Revenue Cycle at Alliance Spine and Pain Centers. 'What I mean by that is understanding what type of calls are coming in and directing them to the right place the first time. Being able to answer those calls more efficiently allows us to speed up wait times.'
She further added, 'It will significantly help improve patient experience, knowing that they can call and talk to someone about a procedure they're preparing to have or just getting feedback on questions related to their care, making them feel heard.'
Alliance Spine and Pain Centers has 20 locations across Georgia, and its team, which includes best-in-class physicians, medical professionals, and administrators, is dedicated to bringing relief to people suffering from chronic pain. One of its biggest challenges is managing the ever-increasing number of incoming patient calls. While the practice has two call centers, one dedicated to handling billing questions, the long wait time makes the patients call back or leave a voicemail. The medical staff often must manage voicemails or telephone encounters simultaneously.
By offering patients 24/7 access to vital health information via voice call, text, or chatbot with zero waiting time, healow Genie can significantly help enhance patient satisfaction, reduce administrative burdens on staff, and lower overall operational costs.
"By transforming the way medical practices connect with their patients, healow Genie is bringing the future of patient engagement to the present," said Girish Navani, CEO of eClinicalWorks. 'The integration with healow Genie can manage routine tasks like appointment scheduling and medication refills, allowing medical staff to focus on delivering quality care.'
healow Genie offers a comprehensive suite of features, including patient self-service, an intelligent assistant, automated after-hours service, and conversational smart campaigns.
Hear from Cheraire Lyons in this video to learn more about the practice's story and how they expect healow Genie to improve efficiency and patient satisfaction.
About Alliance Spine and Pain Centers
With 20 locations across Georgia, Alliance Spine and Pain Centers is dedicated to bringing real relief to people suffering from chronic pain. The practice's team includes best-in-class physicians, medical professionals, and administrators. Together, they provide their patients with the best pain management treatment while leading the way to the future of pain relief. For more information, visit www.spinepains.com.
About eClinicalWorks
eClinicalWorks ® was founded in 1999 to help digitize paper charts for ambulatory practices. Today, eClinicalWorks leads the nation in innovation with cloud-based solutions for Electronic Health Records and Practice Management. In addition, we help ambulatory practices, specialists, health centers, urgent care facilities, and hospital systems manage their revenue cycle, patient relationships, and Population Health initiatives. More than 180,000 providers and nearly 1 million medical professionals rely upon the power and scalability of the eCW Cloud for flexible clinical documentation, better front-office workflows, and more efficient billing driven by Robotic Process Automation. We combine innovation, leading-edge technology, and a commitment to patient safety to enable practices to grow and thrive amid the challenges of 21st-century healthcare. For more information, visit www.eclinicalworks.com, follow us on LinkedIn, Facebook and X/Twitter, or call (866) 888-6929.
About healow Genie
healow® Genie is a first-of-its-kind, EHR-agnostic, AI-powered contact center solution designed to enhance patient engagement by providing patients 24/7 access to vital health information via voice call, text, or chatbot. It offers a comprehensive suite of features, including patient self-service, intelligent assistant, automated after-hours service, and conversational smart campaigns. Genie improves patient satisfaction, reduces administrative burdens on staff, and lowers overall operational costs. For more information, visit genie.healow.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
44 minutes ago
- Business Upturn
Lupin launches Bosentan Tablets for Oral Suspension in US with 180-day exclusivity
By Aditya Bhagchandani Published on August 20, 2025, 10:16 IST Shares of Lupin Ltd. will be in focus on Wednesday, August 20, after the company announced the launch of Bosentan Tablets for Oral Suspension, 32 mg, in the United States. The launch, made in partnership with NATCO Pharma, comes with the advantage of 180-day first-to-file generic exclusivity, a significant opportunity in the niche space of pulmonary arterial hypertension (PAH) treatment. The government filing confirmed that Lupin's alliance partner NATCO Pharma received U.S. FDA approval for its Abbreviated New Drug Application (ANDA). Bosentan is indicated for the treatment of PAH in pediatric patients aged three years and above with idiopathic or congenital PAH, aiming to improve pulmonary vascular resistance and exercise ability. The drug is bioequivalent to Actelion Pharmaceuticals' Tracleer® Tablets for Oral Suspension, which had estimated annual U.S. sales of around USD 10 million as of June 2025. Lupin, a major player in generics and specialty formulations, continues to strengthen its U.S. portfolio with this launch. The company has a strong footprint across therapy areas, including respiratory, cardiovascular, anti-diabetic, and women's health, and operates 15 manufacturing sites and seven research centers globally. With the exclusivity window, Lupin and NATCO are positioned to capture market share in the PAH treatment segment before competition intensifies. Disclaimer: This article is for informational purposes only and should not be considered investment advice. Please consult a financial advisor before making any investment decisions. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Wire
9 hours ago
- Business Wire
Small Medical Practices Are Sitting Ducks for Healthcare Cybercrime
SAN FRANCISCO--(BUSINESS WIRE)--Over 90% of U.S. healthcare providers operate as small organizations, yet a new Paubox report titled "What small healthcare practices get wrong about HIPAA and email security" reveals these practices are unknowingly exposing themselves to cyber attacks and federal compliance violations. 98% of small healthcare organizations falsely believe they're HIPAA compliant Share The study of 214 healthcare IT leaders and practice managers at organizations with fewer than 250 employees found that nearly all small practices (98%) claim their platforms "encrypt emails by default"—but most are using common tools like Microsoft 365 or Google Workspace that often fail to provide actual protection. "Nearly half of healthcare email breaches stem from Microsoft 365 alone," the survey found. The problem is that encryption may drop if a recipient's server doesn't support modern protocols, often without any alert to the sender—leaving protected health information completely exposed. The confidence crisis More than 80% of small practices expressed confidence in their current HIPAA compliance posture, but the reality is far different. The survey found widespread misconceptions that are creating massive compliance gaps: 83% believe patient consent removes the need for encryption—a costly misunderstanding. Federal regulations still require "appropriate safeguards" under the HIPAA Security Rule, even when patients agree to electronic communication. Getting a patient's okay to email doesn't eliminate the legal requirement for encryption and other protective measures. 64% believe patient portals are required for HIPAA compliance—yet the regulations say the opposite. HIPAA explicitly gives patients the right to request communication "by alternative means or at alternative locations, if reasonable." Portals are just one option among many, including secure direct email when proper safeguards are in place. 20% don't utilize any form of email archiving or audit trail—leaving one in five practices unable to investigate incidents after they happen or prove compliance during federal audits. These misconceptions create compliance violations that practices don't even realize exist, with healthcare providers unknowingly breaking federal law while genuinely believing they're following the rules. Cybercriminals target the vulnerable Phishing attacks—the leading cause of healthcare breaches—now account for over 70% of healthcare data breaches as of 2024. Small practices are prime targets because they typically lack dedicated security staff, formal training programs, or technical defenses. The survey found that 43% of small healthcare organizations reported experiencing a phishing or spoofing incident in the past year. Meanwhile, about 50% of these organizations lack anti-phishing controls beyond default spam filters, and nearly 99% have not implemented secure email transfer protocols. "Phishing attacks have evolved—they're faster, smarter, and relentless," noted Paubox CEO, Hoala Greevy. "It's not about one-off scams anymore; it's deception at scale." Beyond the breach When breaches occur, small practices face the same serious consequences as large health systems. Recent examples from the past year include: Solara Medical : $9.76 million class-action settlement following a phishing attack : $9.76 million class-action settlement following a phishing attack Sunrise Community Health : Email compromise affecting 54,000+ patients : Email compromise affecting 54,000+ patients Salud Family Health: Phishing attack exposing 80,000+ records Even smaller penalties come with major operational costs. Agape Health, a North Carolina clinic, paid $25,000 for emailing protected health information unencrypted to the wrong recipient, while Vision Upright MRI faced a $5,000 fine plus two years of federal monitoring after a server breach exposed over 21,000 individuals' medical imaging records. In 2025, healthcare breaches took an average of 224 days to detect and another 84 days to contain—over 10 months total. Without proper audit trails, many small organizations lack the systems to spot breaches until it's too late. Stretched thin and vulnerable The survey found that small healthcare practices are operating under dangerous constraints that create the perfect storm for security failures: One-third report not having enough time for compliance tasks—meaning critical security measures get pushed aside during busy patient care schedules. The same number have no clear policies or procedures in place, leaving staff to make up security protocols on the fly. Only half have phishing or spoofing protection enabled, despite facing the same sophisticated attacks that target major health systems. Meanwhile, the average small healthcare employee has access to more than 5,500 sensitive files—creating massive exposure when those unprotected phishing emails inevitably get through. This combination of time pressure, unclear guidance, and broad data access means a single clicked link can expose thousands of patient records. It's a vulnerability that cybercriminals are increasingly exploiting. What HIPAA investigators look for When HHS investigators arrive after a breach, they look for specific documentation that most small practices can't provide: Proof that protected health information was encrypted in transit—not just that platforms "support" encryption Audit logs showing who sent what to whom and whether it was properly protected Evidence of risk assessments documenting understood vulnerabilities Incident response procedures for when things go wrong "Every organization, no matter the size, is required to comply with the HIPAA Security Rule," emphasized Melanie Fontes Rainer, Director of the HHS Office for Civil Rights. "Risk assessments are not optional—they're foundational." The path forward With federal enforcement ramping up and cybercriminals increasingly targeting small practices, the window for voluntary compliance is closing fast. The practices that are getting ahead of this crisis share a common strategy: they've stopped relying on overworked staff to make perfect security decisions every time. Instead, they're implementing systems that encrypt every message automatically, maintain detailed audit trails without extra effort, and block phishing attacks before employees ever see them. "The cost of compliance is far less than the cost of a breach," the survey noted—and recent settlements prove it. At $25,000 to $9.76 million per incident, even "small" violations can devastate a practice's finances and reputation. For the 90% of healthcare providers operating as small organizations, the math is simple: invest in automated protection now, or face the much higher costs of breach response, federal penalties, and lost patient trust later. The choice is becoming less optional every day. The complete report, "What small healthcare practices get wrong about HIPAA and email security," is available for download at About Paubox Paubox is a leader in HIPAA compliant communication and marketing solutions for healthcare organizations. According to G2 rankings, Paubox leads the industry for Best Secure Email Gateway, Email Security, HIPAA Compliant Messaging Software, and Email Encryption solution, and is the only HIPAA compliant email company listed on G2's 2025 Best Healthcare Software Products. Paubox solutions include Paubox Email Suite, Paubox Marketing, Paubox Email API, Paubox Forms, and Paubox Texting. Launched in 2015, Paubox is trusted by over 7,000 healthcare organizations, including Cost Plus Drugs, Covenant Health, Devry University, and SimonMed Imaging.
The Hill
9 hours ago
- The Hill
Novo Nordisk, GoodRx selling Ozempic at half cost for customers paying cash
Novo Nordisk and GoodRx announced a partnership this week to sell products Ozempic and Wegovy at half their normal cost to patients who pay for the medications with cash. Starting this week, customers will be able to buy a month's supply of Novo Nordisk's semaglutide pen products for $499 through GoodRx. The list price for a monthly supply of a product like Ozempic is normally around $1,000 or more without insurance. 'Demand for GLP-1 medications is at an all-time high, but too many Americans still face barriers accessing them,' GoodRx CEO and President Wendy Barnes said in a statement. 'By partnering with Novo Nordisk, we're taking a significant step forward in making these innovative brand-name treatments more accessible for millions of people who need them,' added Barnes. 'It's a powerful example of how the GoodRx platform can deliver savings at scale—bridging gaps in coverage and ensuring more people can get the care they deserve.' This is the most recent in similar moves Novo Nordisk has made to make its popular diabetes and weight loss medication more widely available. Earlier this year, the company announced a direct-to-patient program called NovoCare® Pharmacy for uninsured and underinsured individuals who can pay $499 a month for Wegovy. Novo Nordisk also partnered with online telehealth companies like Ro and LifeMD to sell its pens at the same price point. The telehealth company Hims & Hers was also originally included in the partnership, but Novo Nordisk ended it after accusing the company of illegally selling compounded versions of semaglutide. Hims & Hers maintains it is providing personalized, compounded products within regulatory guidelines. 'Improving access to effective FDA-approved treatment is central to our mission, and our collaboration with GoodRx allows us to reach those who seek savings and support from their trusted and established platform,' Dave Moore, executive vice president of U.S. operations of Novo Nordisk, said in a statement. 'This initiative enables us to meet GoodRx patients where they are with our authentic GLP-1 medicines in addition to supporting the launch of the new Ozempic® self-pay offer for type 2 diabetes patients at an unprecedented price.' Sen. Bernie Sanders (I-Vt.), a prominent critic of high drug costs, called the announcement a 'modest step forward.' 'Novo Nordisk's move to cut the price of Ozempic to $499 for the uninsured is a modest step forward, but let's not forget,' Sanders said on the social media platform X. 'Ozempic costs just $59 in Germany while it costs less than $5 to make. The U.S. must no longer pay the highest prices in the world for prescription drugs.
